While there are more than 20 different described fusion partners for ALK, the most frequent fusion in NSCLC is the one between the 3′ region of the ALK gene and the 5′ region of the echinoderm microtubule-associated protein-like 4 (EML4) gene [69]. The gene discussed is EML4; the disease is non-small cell lung carcinoma.